Freemont Management S.A. significantly increased its stake in Williams Companies, Inc. (NYSE:WMB) by 197.1% during the fourth quarter, now owning 41,600 shares valued at $2,501,000. Other institutional investors like Vanguard Group Inc., Wellington Management Group LLP, and Invesco Ltd. also adjusted their holdings. Wall Street analysts maintain a "Buy" consensus rating for Williams Companies, with a target price of $80.47, following strong Q1 earnings and dividend declarations, despite some insider stock sales.

Freemont Management S.A. increased its stake in The Boeing Company by 200% in the fourth quarter, purchasing an additional 4,600 shares, bringing its total holdings to 6,900 shares valued at $1.498 million. Other institutional investors like Revolve Wealth Partners LLC, Sivia Capital Partners LLC, AXA S.A., Ieq Capital LLC, and Alliancebernstein L.P. also adjusted their holdings in Boeing, with institutional investors now owning 64.82% of the company's stock. The article also details Boeing's recent financial performance, analyst ratings, and impacting news, including potential large jet deals with China and April's surge in new order bookings.

Centene Corp (US15133V1035) shares surged 6.0% to $59.31 on May 12, 2026, amid a recovery in the healthcare sector, particularly in managed care. The company, a leading provider of health insurance and services primarily through government-sponsored programs, saw its stock rise, reflecting ongoing stabilization despite industry pressures from rising medical costs and regulatory changes. This movement highlights Centene's strong competitive position as the largest Medicaid provider by membership.

E Fund Management Hong Kong Co. Ltd. significantly increased its stake in Costco Wholesale Corporation by 371.6% in the fourth quarter, now owning 1,792 shares valued at $1.545 million. This comes as Costco reported strong earnings, exceeding expectations with $4.58 EPS and $69.6 billion in revenue, alongside a 9.2% sales increase year-over-year. The company also raised its quarterly dividend to $1.47 per share, and analysts maintain a "Moderate Buy" consensus with an average price target of $1,047.27.

Bank Julius Baer & Co. Ltd Zurich has reduced its holding in Motorola Solutions (MSI) by 14.9% during the fourth quarter, selling 22,426 shares and retaining 127,965 shares valued at approximately $49.1 million. Despite this reduction, Motorola Solutions reported strong earnings, beating expectations with $3.37 EPS and $2.71 billion in revenue, a 7.4% year-over-year increase. Analysts generally maintain a "Buy" rating for MSI with a consensus price target of $504.67.

Bradyco Inc. reduced its stake in Costco Wholesale Corporation by 18.3% in the fourth quarter, now holding 6,389 shares valued at $5.51 million. Despite this reduction, Costco remains Bradyco's fourth-largest position, accounting for 6.8% of its holdings. Other institutional investors like Assenagon Asset Management S.A. and Amundi significantly increased their holdings in Costco during the same period.

Freemont Management S.A. recently acquired a new stake of 6,600 shares, valued at approximately $5.09 million, in Regeneron Pharmaceuticals (NASDAQ:REGN) during the fourth quarter. Other institutional investors also adjusted their holdings in the biopharmaceutical company. Regeneron Pharmaceuticals reported strong quarterly earnings, surpassing analyst estimates, and announced a quarterly dividend.

Bank Julius Baer & Co. Ltd Zurich has a significant stock position in Republic Services, Inc., holding 334,016 shares valued at $70.89 million despite reducing its stake by 22.1% in the fourth quarter. Republic Services reported strong Q1 results, exceeding EPS and revenue expectations, and declared a quarterly dividend. Insider buying, notably by major shareholder Cascade Investment, indicates confidence in the company's outlook.

Thermo Fisher Scientific reported strong Q1 2026 earnings, with EPS of $5.44, surpassing consensus estimates by 4.62%. This performance, coupled with a 0.37% after-market stock rise, reinforces the company's robust position in the life sciences sector. The company's diversified portfolio and structural growth in the life sciences industry are key drivers of its sustained operational momentum.

MetLife shares have rebounded following a strong Q1 earnings beat that surpassed Wall Street expectations, attracting positive attention from analysts. JP Morgan and Keefe Bruyette & Woods both raised their price targets for the insurer, with Keefe Bruyette & Woods upgrading its rating to Outperform. This renewed analyst confidence signals strength in MetLife's operational execution and earnings power, supporting its stock recovery despite an initial post-earnings dip.